相关实验视频
Updated: May 7, 2026

05:37
Intravitreous Injection for Establishing Ocular Diseases Model
Published on: October 1, 2007
36.7K
在中国眼科医生中,静脉内注射的实践模式
Li Su1,2,3, Yin-Chen Shen1,2,3, Hong Li4
1Department of Ophthalmology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200080, China.
International journal of ophthalmology
|September 19, 2024
概括
这项调查揭示了中国眼科医生当前的视内注射 (IVI) 实践,突出了对安全协议的遵守以及注射前后程序的变化. 调查结果为中国IVI的培训和指导方针制定提供了信息.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 眼科手术 眼科手术
背景情况:
- 静脉内注射 (IVI) 是各种视网膜疾病的基石治疗.
- 标准化的实践模式对于优化患者的治疗结果和尽量减少并发症至关重要.
研究的目的:
- 在中国的眼科医生中,概述眼膜内注射 (IVI) 的当前实践模式.
- 确定IVI程序的潜在标准化和改进的领域.
主要方法:
- 在中国的眼科医生中进行了一项横截面的匿名在线调查.
- 参与者已经进行了100多次静脉注射,并被询问了注射前,注射后和注射后的技术和程序.
主要成果:
- 333名眼科医生做出回应,高度遵守预防性抗生素 (100%) 和无菌技术 (例如口罩99.7%,手套99.4%) 等安全措施.
- 在瞳孔膨胀 (61.26%),双边注射 (51.05%) 和注射后评估 (IOP 32.43%,视神经 perfusion 36.94%) 中注意到了变化.
- 上象限是最常见的注射部位 (40.54%),经常使用30尺针 (约. 75%) 的比例.
结论:
- 该研究提供了对中国现实世界内注射实践的全面概述.
- 研究结果为完善眼科医生教育,培训计划和当地社会对IVI的指导方针提供了宝贵的见解.
相关概念视频
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

